Immatics Stock Financials

IMTX -  USA Stock  

USD 7.30  0.16  2.14%

Understanding current and past Immatics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Immatics' financial statements are interrelated, with each one affecting the others. For example, an increase in Immatics' assets may result in an increase in income on the income statement. Because of this, it is necessary to analyze all of Immatics' financials over time to get the whole picture.
Immatics Enterprise Value is fairly stable at the moment as compared to the past year. Immatics reported Enterprise Value of 697.51 Million in 2021. Market Capitalization is likely to rise to about 912.3 M in 2022, whereas Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop (93.2 M) in 2022.
Please harness Immatics fundamental data analysis to find out if markets are presently mispricing the company. We were able to interpolate and analyze data for thirty available reported financial drivers for Immatics NV, which can be compared to its competitors. To make sure the equity is not overpriced, please check out all Immatics financials, including its revenue, as well as the relationship between the total debt and earnings per share . Given that Immatics NV has a shares owned by institutions of 36.95 %, we strongly advise you to confirm Immatics NV regular market performance to make sure the company can sustain itself down the road. Use Immatics to protect your portfolios against small market fluctuations. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Immatics to be traded at $7.01 in 90 days.
  
Refresh
With this module, you can analyze Immatics financials for your investing period. You should be able to track the changes in Immatics individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
The fundamental analysis of Immatics is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Immatics includes many different criteria found on its balance sheet. For example, investors should never minimize Immatics' ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Immatics' cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Immatics.

Immatics NV Cash

Chance Of Financial Distress
Less than 28
Immatics NV has less than 28 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Immatics stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Immatics' official financial statements usually reflect Immatics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Immatics NV. For example, before you start analyzing numbers published by Immatics accountants, it's critical to develop an understanding of what Immatics' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Immatics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Immatics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Immatics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Immatics NV. Please utilize our Beneish M Score to check the likelihood of Immatics' management to manipulate its earnings.

Immatics Company Summary

Immatics competes with Berkeley Lights, and Brickell Biotech. Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor based immunotherapies for the treatment of cancer in the United States. The company has a strategic collaboration agreement with GlaxoSmithKline Intellectual Property Development Limited to develop novel adoptive cell therapies targeting multiple cancer indications MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies Celgene Switzerland LLC to develop novel adoptive cell therapies targeting multiple cancers and Genmab AS to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 188 people.
Specialization
Healthcare, Biotechnology
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
CUSIPG3165V117
LocationGermany
Business AddressPaul-Ehrlich-Strasse 15
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.immatics.com
Phone49 7071 5397 0
Related EntityIMTX
CurrencyUSD - US Dollar
You should never invest in Immatics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Immatics Stock, because this is throwing your money away. Analyzing the key information contained in Immatics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Immatics Key Financial Ratios

Generally speaking, Immatics' financial ratios allow both analysts and investors to convert raw data from Immatics' financial statements into concise, actionable information that can be used to evaluate the performance of Immatics over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Immatics NV reports annually and quarterly.

Immatics Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Immatics's current stock value. Our valuation model uses many indicators to compare Immatics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Immatics competition to find correlations between indicators driving Immatics's intrinsic value. More Info.
Immatics NV is currently regarded as number one stock in beta category among related companies. It is rated second overall in price to sales category among related companies fabricating about  29.05  of Price to Sales per Beta. Price to Sales Ratio is likely to rise to 24.58 in 2022. Comparative valuation analysis is a catch-all model that can be used if you cannot value Immatics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Immatics' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Immatics' earnings, one of the primary drivers of an investment's value.

Immatics NV Systematic Risk

Immatics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Immatics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Immatics NV correlated with the market. If Beta is less than 0 Immatics generally moves in the opposite direction as compared to the market. If Immatics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Immatics NV is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Immatics is generally in the same direction as the market. If Beta > 1 Immatics moves generally in the same direction as, but more than the movement of the benchmark.
.

About Immatics Financials

What exactly are Immatics Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Immatics' income statement, its balance sheet, and the statement of cash flows. Potential Immatics investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Immatics investors may use each financial statement separately, they are all related. The changes in Immatics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Immatics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines that you should keep in mind when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase year after year due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt to equity ratio because this number will tell you how much risk it has. If a company such as Immatics is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to try and figure out if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that net revenue of Immatics grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only grown by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Immatics May 28, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Immatics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Immatics NV. We use our internally-developed statistical techniques to arrive at the intrinsic value of Immatics NV based on widely used predictive technical indicators. In general, we focus on analyzing Immatics Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Immatics's daily price indicators and compare them against related drivers.
Information Ratio(0.032301)
Maximum Drawdown20.84
Value At Risk(6.31)
Potential Upside7.24
Please see Risk vs Return Analysis. Note that the Immatics NV information on this page should be used as a complementary analysis to other Immatics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Immatics Stock analysis

When running Immatics NV price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Is Immatics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immatics. If investors know Immatics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immatics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immatics NV is measured differently than its book value, which is the value of Immatics that is recorded on the company's balance sheet. Investors also form their own opinion of Immatics' value that differs from its market value or its book value, called intrinsic value, which is Immatics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immatics' market value can be influenced by many factors that don't directly affect Immatics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immatics' value and its price as these two are different measures arrived at by different means. Investors typically determine Immatics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immatics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.